Parsifal Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AvePoint
AVPT
|
+$33.5M |
| 2 |
Albertsons Companies
ACI
|
+$31.4M |
| 3 |
Grand Canyon Education
LOPE
|
+$24.5M |
| 4 |
UnitedHealth
UNH
|
+$15.7M |
| 5 |
Core Scientific
CORZ
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$55.8M |
| 2 |
Globus Medical
GMED
|
+$41M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$33.9M |
| 4 |
Cigna
CI
|
+$23.2M |
| 5 |
Atmus Filtration Technologies
ATMU
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.51% |
| 2 | Consumer Staples | 27.72% |
| 3 | Healthcare | 17.94% |
| 4 | Technology | 16.89% |
| 5 | Industrials | 8.93% |
Similar funds
Parsifal Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Parsifal Capital Management held 17 positions worth $1.2B, down 18% from $1.46B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Parsifal Capital Management withdrew a net $294M in Q4 2024, closing 1 position and reducing 9 holdings. Its largest reduction was Brightstar Lottery PLC, cutting an estimated $55.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 30% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Parsifal Capital Management opened a new position in AvePoint worth $36.4M.
- Parsifal Capital Management's largest Q4 2024 buy was AvePoint: 2,205,900 shares worth $36.4M.
- Parsifal Capital Management added most to Albertsons Companies in Q4 2024, an estimated $31.4M increase.
- Parsifal Capital Management's biggest Q4 2024 reduction was Brightstar Lottery PLC, cutting an estimated $55.8M.
- Parsifal Capital Management's ten largest holdings make up 87% of its $1.2B portfolio in Q4 2024.
- Parsifal Capital Management opened 2 new positions and closed 1 in Q4 2024.
- Parsifal Capital Management's portfolio value fell 18% quarter-over-quarter to $1.2B.
Based on Parsifal Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.